Your browser doesn't support javascript.
loading
Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer.
Keresztes, Dávid; Csizmarik, Anita; Nagy, Nikolett; Módos, Orsolya; Fazekas, Tamás; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Sevcenco, Sabina; Kramer, Gero; Shariat, Shahrokh; Küronya, Zsófia; Takács, László; Tornyi, Ilona; Lázár, József; Hadaschik, Boris; Lászik, András; Szucs, Miklós; Nyirády, Péter; Szarvas, Tibor.
Afiliación
  • Keresztes D; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Csizmarik A; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Nagy N; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Módos O; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Fazekas T; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Bracht T; Medical Faculty, Medizinisches Proteom-Center, Ruhr-University Bochum, Bochum, Germany.
  • Sitek B; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, Germany.
  • Witzke K; Center for Protein Diagnostics, Medical Proteome Analysis, Ruhr-University Bochum, Bochum, Germany.
  • Puhr M; Medical Faculty, Medizinisches Proteom-Center, Ruhr-University Bochum, Bochum, Germany.
  • Sevcenco S; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, Germany.
  • Kramer G; Center for Protein Diagnostics, Medical Proteome Analysis, Ruhr-University Bochum, Bochum, Germany.
  • Shariat S; Medical Faculty, Medizinisches Proteom-Center, Ruhr-University Bochum, Bochum, Germany.
  • Küronya Z; Center for Protein Diagnostics, Medical Proteome Analysis, Ruhr-University Bochum, Bochum, Germany.
  • Takács L; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
  • Tornyi I; Department of Urology, Donauspital, Vienna, Austria.
  • Lázár J; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Hadaschik B; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Lászik A; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary.
  • Szucs M; Department of Human Genetics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Nyirády P; Biosystems International Kft., Debrecen, Hungary.
  • Szarvas T; Department of Human Genetics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
J Cell Mol Med ; 26(4): 1332-1337, 2022 02.
Article en En | MEDLINE | ID: mdl-34970839
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: J Cell Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Reino Unido